References
- Butler T, Levy M, Dolan K, Kaldor J. Drug use and its correlates in an Australian prisoner population. Addict Res Theory 2003; 11: 89–101
- Butler T, Milner L. The 2001 inmate health survey 2003. Corrections Health Service, Sydney, NSW 2003
- Lind B CSWDMR. The effectiveness of methadone maintenance treatment in controlling crime: an aggregate-level analysis. NSW Bureau of Crime Statistics and Research, Sydney, Australia 2004
- Dolan K A, Shearer J, White B, Zhou J, Kaldor J, Wodak A D. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction 2005; 100: 820–828
- Dolan K A, Shearer J, MacDonald M, Mattick R P, Hall W, Wodak A D. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend 2003; 24: 59–65
- Caplehorn J R, Dalton M S, Cluff M C, Petrenas A M. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994; 89: 203–209
- Caplehorn J R, Irwig L, Saunders J B. Attitudes and beliefs of staff working in methadone maintenance clinics. Subst Use Misuse 1996; 31: 437–452
- Caplehorn J R, McNeil D R, Kleinbaum D G. Clinic policy and retention in methadone maintenance. Int J Addict 1993; 28: 73–89
- Caplehorn J R, Lumley T S, Irwig L. Staff attitudes and retention of patients in methadone maintenance programs. Drug Alcohol Depend 1998; 52: 57–61
- Caplehorn J R. A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int J Addict 1994; 29: 1361–1375
- Vossenberg P. Attitudes and beliefs towards methadone of staff working in substance abuse treatment. Heroin Addict Rel Clin Prob 2000; 2: 15–21
- Caplehorn J R, Hartel D M, Irwig L. Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics. Subst Use Misuse 1997; 32: 399–413
- Caplehorn R M, Lumley T S, Irwig L, Saunders J B. Changing attitudes and beliefs of staff working in methadone maintenance programs. Aust NZ J Public Health 1998; 22: 505–508
- Caplehorn J R, Irwig L, Saunders J B. Physicians' attitudes and retention of patients in their methadone maintenance programs. Subst Use Misuse 1996; 31: 663–677
- Rich J D, Boutwell A E, Shield D C, et al. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health 2005; 82: 411–419
- Lovecchio F, Pizon A, Riley B, Sami A, D'Incognito C. Onset of symptoms after methadone overdose. Am J Emerg Med 2007; 25: 57–59
- Marsch L A, Stephens M A, Mudric T, Strain E C, Bigelow G E, Johnson R E. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Exp Clin Psychopharmacol 2005; 13: 293–302
- Johnson R E, Chutuape M A, Strain E C, Walsh S L, Stitzer M L, Bigelow G E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med 2000; 343: 1290–1297
- Stella L, D'Ambra C, Mazzeo F, et al. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients. Life Sci 2005; 77: 2717–2722
- Cornish J W, Metzger D, Woody G E, et al. Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 1997; 14: 529–534
- Caplehorn J. Confirmatory testing of the AO scale and DDU scale, L Gjersing. Personal communication. 2003
- Caplehorn J. Knowledge of methadone toxicity among US maintenance clinic staff. J Maint Addict 2000; 1: 63–72
- McLellan A T, Arndt I O, Metzger D S, Woody G E, O'Brien C P. The effects of psychosocial services in substance abuse treatment. JAMA 1993; 269: 1953–1959